| |
| |
|
| Insider
Information: |
Cornelius James M |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
79,851 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,293,055 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
79,851 |
|
|
| Total
Value |
$3,293,055 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
3.0
|
| Percentage
Gain/Loss : |
 -4.0%
|
 70.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
Director |
2015-03-31 |
79,851 |
|
0 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2014-10-15 |
4 |
S |
$48.92 |
$4,892,000 |
D/D |
(100,000) |
169,041 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
• • – |
2012-09-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
150,000 |
1,119,711 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
156,096 |
1,150,229 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2011-04-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
165,455 |
574,699 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman & CEO |
• • – |
2010-03-10 |
4 |
GD |
$25.65 |
$4,360,500 |
D/D |
170,000 |
391,054 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2011-08-11 |
4 |
OE |
$17.51 |
$3,502,000 |
D/D |
200,000 |
492,628 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
• • – |
2013-05-17 |
4 |
OE |
$22.14 |
$4,560,751 |
D/D |
205,996 |
957,820 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
• • – |
2013-05-17 |
4 |
AS |
$42.98 |
$9,283,708 |
D/D |
(215,996) |
741,824 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman & CEO |
• • – |
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
278,347 |
510,664 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2011-04-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
282,934 |
291,765 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
369,472 |
738,309 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
• • – |
2012-08-14 |
4 |
A |
$22.14 |
$8,856,000 |
D/D |
400,000 |
1,274,711 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
• • – |
2012-12-12 |
4 |
A |
$22.14 |
$8,856,000 |
D/D |
400,000 |
1,290,451 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2011-10-31 |
4 |
OE |
$17.51 |
$7,707,692 |
D/D |
440,188 |
1,433,612 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2011-10-31 |
4 |
S |
$31.87 |
$14,029,804 |
D/D |
(440,188) |
993,424 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2011-09-26 |
4 |
OE |
$17.51 |
$8,755,000 |
D/D |
500,000 |
992,628 |
0 |
- |
|
191 Records found
|
|
Page 8 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
